Cited by 1,001Lipoproteins and Cardiovascular HealthCardiac and Coronary Surgery TechniquesCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Open access

Buchwald, Henry, Varco, Richard L., Matts, John P., Long, John M., Fitch, Laurie L., Campbell, Gilbert S., Pearce, Malcolm B., Yellin, Albert E., Edmiston, W. Allan, Smink, Robert D., Sawin, Henry S., Campos, Christian T., Hansen, Betty J., Tuna, Naip, Karnegis, James N., Sanmarco, Miguel E., Amplatz, Kurt, Castaneda-Zuniga, Wilfredo R., Hunter, David W., Bissett, Joseph K., Weber, Frederic J., Stevenson, James W., Leon, Arthur S., Chalmers, Thomas C.·1990·New England Journal of Medicine

DOI 10.1056/nejm199010043231404

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND AND METHODS: The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether cholesterol lowering induced by the partial ileal bypass operation would favorably affect overall mortality or mortality due to coronary heart disease. The study population consisted of 838 patients (417 in the control group and 421 in the surgery group), both men (90.7 percent) and women, with an average age of 51 years, who had survived a first myocardial infarction. The mean follow-up period was 9.7 years. RESULTS: When compared with the control group at five years, the surgery group had a total plasma cholesterol level 23.3 percent lower (4.71 +/- 0.91 vs. 6.14 +/- 0.89 mmol per liter [mean +/- SD]; P less than 0.0001), a low-density lipoprotein cholesterol level 37.7 percent lower (2.68 +/- 0.78 vs. 4.30 +/- 0.89 mmol per liter; P less than 0.0001), and a high-density lipoprotein cholesterol level 4.3 percent higher (1.08 +/- 0.26 vs. 1.04 +/- 0.25 mmol per liter; P = 0.02). Overall mortality and mortality due to coronary heart disease were reduced, but not significantly so (deaths overall [control vs. surgery], 62 vs. 49, P = 0.164; deaths due to coronary disease, 44 vs. 32, P = 0.113). The overall mortality in the surgery subgroup with an ejection fraction greater than or equal to 50 percent was 36 percent lower (control vs. surgery, 39 vs. 24; P = 0.021). The value for two end points combined--death due to coronary heart disease and confirmed nonfatal myocardial infarction--was 35 percent lower in the surgery group (125 vs. 82 events; P less than 0.001). During follow-up, 137 control-group and 52 surgery-group patients underwent coronary-artery bypass grafting (P less than 0.0001). A comparison of base-line coronary arteriograms with those obtained at 3, 5, 7, and 10 years consistently showed less disease progression in the surgery group (P less than 0.001). The most common side effect of partial ileal bypass was diarrhea; others included occasional kidney stones, gallstones, and intestinal obstruction. CONCLUSIONS: Partial ileal bypass produces sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease. The role of this procedure in the management of hypercholesterolemia remains to be determined. These results provide strong evidence supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199010043231404

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Practical Nonparametric Statistics
Groggel, D. J., & Conover, W. J. (2000) · Technometrics · doi:10.2307/1271101 · Cited by 11,076
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,091
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease
(1984) · JAMA · doi:10.1001/jama.1984.03340270029025 · Cited by 2,747
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160

Show all 58 references

Research works printed but not linked: 29

10.1001/jama.256.20.2823 · DOI · Paper page
Leren, 1966, Acta Med Scand Suppl, 466, 1
1968, Lancet, 2, 693
Frantz, 1975, Circulation, 52, II-4
10.1001/jama.231.4.360 · DOI
10.1001/jama.251.3.351 · DOI · Paper page
10.1001/jama.257.23.3233 · DOI
Buchwald H. Intestinal bypass for hypercholesterolemia. In: Nyhus LM, Baker RJ, eds. Mastery of surgery. Vol. 3. Boston: Little, Brown, 1984:901–7.
Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: W.B. Saunders, 1990:1799–819.
Schouten, 1986, Artery, 13, 240
1959, Stat Bull Metrop Life Insur Co, 40, 1
Bruce, 1971, Ann Clin Res, 3, 323
National Heart and Lung Institute, Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75–628.)
1970, Bull World Health Organ, 43, 891
Mantel, 1966, Cancer Chemother Rep, 50, 163
Matts, Controlled Clin Trials
Campos, 1987, Surgery, 102, 424
Campos, 1988, Curr Surg, 45, 380
Campos, 1988, Surg Forum, 39, 193
Addison, 1851, Guys Hosp Rep, 2, 267
Ignatovski, 1908, Izviest Imp Voyenno-med Akad S Petersb, 16, 154
Anitschkow, 1913, Centralbl Allg Pathol Pathol Anat, 24, 1
Wacker, 1913, Münchener Med Wochenschr, 60, 2097
European Coronary Surgery Study Group, 1982, Lancet, 2, 1173
Buchwald, 1965, Surgery, 58, 22
Scott, 1967, Surg Gynecol Obstet, 125, 3
Buchwald, 1963, Circulation, 28, II-649
Moore, 1969, Surgery, 65, 98
Buchwald, Ann Surg

Sorted by citations

Items 101–200 of 1,000

Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients
Binggeli, C., Spieker, L. E., Corti, R., Sudano, I., Stojanovic, V., Hayoz, D., Lüscher, T. F., & Noll, G. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00505-9 · Cited by 179
Residual macrovascular risk in 2013: what have we learned?
(R3i), F. T. R. R. R. I., Fruchart, J., Davignon, J., Hermans, M. P., Al-Rubeaan, K. A., Amarenco, P., Assmann, G., Barter, P. J., Betteridge, J. D., Bruckert, É., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-26 · Cited by 174
Toward the quiescent coronary plaque
MacIsaac, A. I., Thomas, J. A. M. D., & Topol, E. J. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90442-4 · Cited by 166
Inadequate treatment with HMG-CoA reductase inhibitors by health care providers
Marcelino, J. J., & Feingold, K. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00011-3 · Cited by 169
Changes in Sequential Coronary Arteriograms and Subsequent Coronary Events
Buchwald, H. (1992) · JAMA · doi:10.1001/jama.1992.03490110067031 · Cited by 179
Self-citation
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals
Schectman, G., & Hiatt, J. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89459-4 · Cited by 164
Baseline and On-Treatment High-Density Lipoprotein Cholesterol and the Risk of Cancer in Randomized Controlled Trials of Lipid-Altering Therapy
Jafri, H., Alsheikh-Ali, A. A. A., & Karas, R. H. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.069 · Cited by 160
Effect of Bariatric Surgery on Cardiovascular Risk Profile†Drs. Heneghan and Meron-Eldar contributed equally to this article.
Heneghan, H., Eldar, S. M., Brethauer, S. A., Schauer, P. R., & Young, J. B. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.076 · Cited by 161
Differential Effects of Lipid-Lowering Therapies on Stroke Prevention
Corvol, J., Bouzamondo, A., Sirol, M., Hulot, J., Sanchez-Peña, P., & Lechat, P. P. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.6.669 · Cited by 162
Intestinal Bile Acid Transport: Biology, Physiology, and Pathophysiology
Shneider, B. L. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200104000-00002 · Cited by 159
Enterohepatic cycling of bilirubin: A putative mechanism for pigment gallstone formation in ileal Crohn's disease☆, ☆☆
BRINK, M., Slors, J. F. M., Keulemans, Y. C. A., Mok, K. S., DEWAART, D., Carey, M. C., Groen, A. K., & Tytgat, G. N. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70507-x · Cited by 155
The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL‐cholesterol plasma concentrations and the course of coronary heart disease*
Schuff‐Werner, P., Gohlke, H., Bartmann, U., Baggio, G., Corti, M. C., Dinsenbacher, A., Eisenhauer, T., Grützmacher, P., Keller, C., Kettner, U., et al. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01068.x · Cited by 150
Bile acids in drug discovery
Enhsen, A., Kramer, W., & Wess, G. (1998) · Drug Discovery Today · doi:10.1016/s1359-6446(96)10046-5 · Cited by 150
Serum Lipids and Incidence of Coronary Heart Disease
Frost, P. H., Davis, B. R., Burlando, A. J., Curb, J. D., Guthrie, G. P., Isaacsohn, J. L., Wassertheil-Smoller, S. W., Wilson, A. C., & Stamler, J. (1996) · Circulation · doi:10.1161/01.cir.94.10.2381 · Cited by 147
Cholesterol reduction yields clinical benefits: meta-analysis including recent trials
Gould, A. L., Davies, G., Alemao, E., Yin, D., & Cook, J. R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.05.012 · Cited by 147
Estimating the Benefits of Modifying Risk Factors of Cardiovascular Disease
Grover, S. A., Paquet, S., Levinton, C. M., Coupal, L., & Zowall, H. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.655 · Cited by 146
Cholesterol inhibition, cancer, and chemotherapy
Buchwald, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90744-n · Cited by 146
Self-citation
Low-density lipoproteins and risk for coronary artery disease
Ballantyne, C. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00769-3 · Cited by 145
Understanding the molecular mechanisms of statin pleiotropic effects
German, C. A., & Liao, J. K. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03492-6 · Cited by 160
When to Start Cholesterol-Lowering Therapy in Patients With Coronary Heart Disease
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G. F., Greenland, P., Hiratzka, L. F., Miller, N. H., Kris‐Etherton, P. M., Krumholz, H. M., LaRosa, J. C., et al. (1997) · Circulation · doi:10.1161/01.cir.95.6.1683 · Cited by 140
Clinical implications for statin pleiotropy
Liao, J. K. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000191913.16321.60 · Cited by 139
Untitled work
Robinson (2012) · doi:10.1016/j.amjcard.2012.07.007 · Cited by 137
Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis
Heffron, S. P., Parikh, A., Volodarskiy, A., Ren‐Fielding, C. J., Schwartzbard, A. Z., Nicholson, J., & Bangalore, S. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.02.004 · Cited by 140
Bile acids: short and long term effects in the intestine
Bajor, A., Gillberg, P., & Abrahamsson, H. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521003702734 · Cited by 142
The Role of Coronary Angiography and Coronary Revascularization Before Noncardiac Vascular Surgery
Mason, J. (1995) · JAMA · doi:10.1001/jama.1995.03520480039037 · Cited by 143
Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia.
Bertolini, S., Bon, G., Campbell, L., Farnier, M., Langan, J., Mahla, G., Pauciullo, P., Sirtori, C., Egros, F., Fayyad, R., et al. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06052-2 · Cited by 140
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients
Tonolo, G., Melis, M. G., Formato, M., Angius, M. F., Carboni, A., Brizzi, P., Ciccarese, M., Cherchi, G. M., & Maioli, M. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00735.x · Cited by 135
What role for statins? A review and economic model.
Ebrahim, S. B. J., Smith, G. D., McCabe, Payne, Pickin, Sheldon, T., Lampe, F. C., Sampson, F. C., Ward, S. E., & Wannamethee, S. G. (1999) · Health Technology Assessment · doi:10.3310/hta3190 · Cited by 134
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
Briel, M., Studer, M., Glass, T. R., & Bucher, H. C. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.022 · Cited by 134
Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
MAS, R., CASTANO, G., ILLNAIT, J., FERNANDEZ, L., FERNANDEZ, J., ALEMAN, C., PONTIGAS, V, & LESCAY, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70139-6 · Cited by 130
Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia
Duell, P. B., Santos, R. D., Kirwan, B., Witztum, J. L., Tsimikas, S., & Kastelein, J. J. P. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.04.013 · Cited by 132
HMG-CoA Reductase Inhibitor Increases GTP Cyclohydrolase I mRNA and Tetrahydrobiopterin in Vascular Endothelial Cells
Hattori, Y., Nakanishi, N., Akimoto, K., Yoshida, M., & Kasai, K. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054659.72231.a1 · Cited by 127
Critical analysis of coronary artery bypass graft surgery: a 30-year journey.
Favaloro, R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00559-7 · Cited by 130
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
Sacks, F. M., Pfeffer, M. A., Moyé, L. A., Brown, L. E., Hamm, P., Cole, T. G., HAWKINS, C. M., D, E. B. M., & The CARE Investigators (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90276-q · Cited by 125
Strategies to achieve coronary arterial plaque stabilization
Rabbani, R. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00279-x · Cited by 125
Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease
Biyyani, R. S. R. S., Putka, B. S., & Mullen, K. D. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.021 · Cited by 123
Management of peripheral arterial disease.
Gey, D., Lesho, E. P., & Manngold, J. (2004) · PubMed · Cited by 123
Quantitative and qualitative coronary angiographic analysis: Review of methods, utility, and limitations
Hermiller, J. B., Cusma, J. T., Spero, L. A., Fortin, D. F., Harding, M. B., & Bashore, T. M. (1992) · Catheterization and Cardiovascular Diagnosis · doi:10.1002/ccd.1810250207 · Cited by 125
Clustering of cardiovascular risk factors: Targeting high-risk individuals
Genest, J. J., & Cohn, J. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80010-4 · Cited by 123
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association.
Betteridge, D., Dodson, P., Durrington, P., Hughes, E., Laker, M., Nicholls, D., Rees, J., Seymour, C., Thompson, G., Winder, A., et al. (1993) · Postgraduate medical journal · doi:10.1136/pgmj.69.811.359 · Cited by 119
In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression
Tsimikas, S., Shortal, B. P., Witztum, J. L., & Palinski, W. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.689 · Cited by 123
Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis
Waters, D. D., Lespérance, J., Gladstone, P. J., Boccuzzi, S. J., Cook, T. J., Hudgin, R. L., Krip, G., & Higginson, L. (1996) · Circulation · doi:10.1161/01.cir.94.4.614 · Cited by 120
Cholesterol and recurrent events: A secondary prevention trial for normolipidemic patients
Pfeffer, M. A., Sacks, F. M., Moyé, L. A., Brown, L., Rouleau, J. L., Hartley, L. H., Rouleau, J. R., Grimm, R. H., Sestier, F., Wickemeyer, W. J., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80478-0 · Cited by 121
The Role of Tobacco Cessation, Antiplatelet and Lipid-Lowering Therapies in the Treatment of Peripheral Arterial Disease
Hirsch, A. T., Treat‐Jacobson, D., Lando, H. A., & Hatsukami, D. K. (1997) · Vascular Medicine · doi:10.1177/1358863x9700200314 · Cited by 118
How to Choose and Use Bariatric Surgery in 2015
Piché, M., Auclair, A., Harvey, J., Marceau, S., & Poirier, P. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.12.014 · Cited by 121
Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Robinson, J. G., & Goldberg, A. C. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.451 · Cited by 120
Enterohepatic cycling of bilirubin as a cause of ‘black’ pigment gallstones in adult life
Vı́tek, L., & Carey, M. C. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01214.x · Cited by 118
Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors
CAMPEAU, L. A., Hunninghake, D. B., Knatterud, G. L., White, C. W., DOMANSKI, M. J., Forman, S. A., Forrester, J. S., Geller, N. L., Gobel, F. L., Herd, J. A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.25.3241 · Cited by 117
A Phase 3 Study of Evolocumab (AMG 145) in Statin-Treated Japanese Patients at High Cardiovascular Risk
Kiyosue, A., Honarpour, N., Kurtz, C., Xue, A., Wasserman, S. M., & Hirayama, A. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.10.021 · Cited by 114
Adenovirus-mediated transfer of a gene encoding cholesterol 7 alpha-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol.
Spady, D. K., Cuthbert, J. A., Willard, M. N., & Meidell, R. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118113 · Cited by 113
An Overview of Trials of Cholesterol Lowering and Risk of Stroke
Hebert, P. R. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430010054007 · Cited by 116
Lipid-lowering interventions in angiographic trials
Rossouw, J. E. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80476-7 · Cited by 110
Management of Familial Hypercholesterolemia: A Review of the Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Robinson, J. G. (2013) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2013.19.2.139 · Cited by 112
Effect of Apheresis of Low-Density Lipoprotein on Peripheral Vascular Disease in Hypercholesterolemic Patients with Coronary Artery Disease
Kroon, A. A., van Asten, W. N. J. C., & Stalenhoef, A. F. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00001 · Cited by 112
Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.
Buchwald, H., Varco, R., Boen, J., Williams, S. E., Hansen, B., Campos, C. T., Campbell, G. S., Pearce, M. B., Yellin, A., Edmiston, W., et al. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.11.1253 · Cited by 121
Self-citation
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data
Crouse, J. R., Byington, R. P., & Furberg, C. D. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00014-8 · Cited by 111
Impact of Restrictive (Sleeve Gastrectomy) vs Hybrid Bariatric Surgery (Roux-en-Y Gastric Bypass) on Lipid Profile
On behalf the Obemar Group, Benaiges, D., Roux, J. A. F., Pedro‐Botet, J., Ramón, J. M., Parri, A., Villatoro, M., Carrera, M. J., Pera, M., Sagarra, E., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0662-8 · Cited by 109
Statins and inflammation: an update
Quist‐Paulsen, P. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283398e53 · Cited by 113
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
Kelloff, G. J., Sigman, C. C., Johnson, K. M., Boone, C. W., Greenwald, P., Crowell, J. A., Hawk, E. T., & Doody, L. A. (2000) · PubMed · Cited by 108
Control de la colesterolemia en España, 2000. Un instrumento para la prevención cardiovascular
Pérez, I. P., Álvarez, F. V., López, P. M., Jiménez, F. P., Galán, A. M., Casasnovas, J. A., Banegas, J. R. B., Abadal, L. T., Rodríguez‐Artalejo, F., & López, E. G. (2000) · Revista Española de Cardiología · doi:10.1016/s0300-8932(00)75163-3 · Cited by 105
Metabolic (Bariatric and Nonbariatric) Surgery for Type 2 Diabetes: A Personal Perspective Review
Buchwald, H., & Buchwald, J. N. (2019) · Diabetes Care · doi:10.2337/dc17-2654 · Cited by 111
Self-citation
Dietary bile acids regulate the hepatic lipid homeostasis in tiger puffer fed normal or high-lipid diets
Liao, Z., Sun, B., Zhang, Q., Jia, L., Wei, Y., Liang, M., & Xu, H. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.734935 · Cited by 106
Placebo‐Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome
Shneider, B. L., Spino, C., Kamath, B. M., Magee, J. C., Bass, L. M., Setchell, K. D. R., Miethke, A. G., Molleston, J. P., Mack, C. L., Squires, R. H., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1244 · Cited by 103
Dietary lipids and coronary heart desease: Old evidence, new persspective
GURR, M. I. (1992) · Progress in Lipid Research · doi:10.1016/0163-7827(92)90009-8 · Cited by 105
Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease A Reappraisal
Pedersen, T. R., & Tobert, J. A. (1996) · Drug Safety · doi:10.2165/00002018-199614010-00003 · Cited by 103
An Evidence-Based Assessment of the NCEP Adult Treatment Panel II Guidelines
Ansell, B. J. (1999) · JAMA · doi:10.1001/jama.282.21.2051 · Cited by 97
The effect of simvastatin on progression of coronary artery disease: The Multicenter Coronary Intervention Study (CIS)
Bestehorn, H.-P., Rensing, U. F. E., Roskamm, H., Betz, P., Benesch, L., Schemeitat, K., Blümchen, G., Claus, J., Mathes, P., KAPPENBERGER, L. J., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015224 · Cited by 99
Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes
Chen, L., Yao, X., Young, A., McNulty, J. A., Anderson, D., Liu, Y., Nystrom, C., Croom, D. K., Ross, S. A., Collins, J. L., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2011 · Cited by 103
Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE−/− mice by SC-435
Bhat, B. G., Rapp, S. R., Beaudry, J. A., Napawan, N., Butteiger, D. N., Hall, K. A., Null, C. L., Luo, Y., & Keller, B. T. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200469-jlr200 · Cited by 99
Treatment of Hyperlipidemia in Women
Walsh, J. M. E. (1995) · JAMA · doi:10.1001/jama.1995.03530140064034 · Cited by 97
Cholesterol Reduction and Stroke Occurrence: An Overview of Randomized Clinical Trials
Mascio, R. D., Marchioli, R., & Tognoni, G. (2000) · Cerebrovascular Diseases · doi:10.1159/000016035 · Cited by 97
Relation of Plasma Levels and Composition of Apolipoprotein B‐Containing Lipoproteins to Angiographically Defined Coronary Artery Disease in Young Patients With Myocardial Infarction
Tornvall, P., Båvenholm, P., Landou, C., de Faire, U., & Hamsten, A. (1993) · Circulation · doi:10.1161/01.cir.88.5.2180 · Cited by 116
Cholesterol-Lowering Interventions and Stroke
Caterina, R. D., Scarano, M., Marfisi, R., Lucisano, G., Palma, F., Tatasciore, A., & Marchioli, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.062 · Cited by 98
Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system
Gordon, B. R., Kelsey, S. F., Bilheimer, D. W., Brown, D. C., Dau, P. C., Gotto, A. M., Illingworth, D. R., Jones, P. H., Leitman, S. F., Prihoda, J. S., et al. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90352-y · Cited by 95
A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician's practice.
Esselstyn, C. B., Ellis, S. G., MEDENDORP, S. V., & Crowe, T. D. (1995) · PubMed · Cited by 93
Results of surgery: long-term effects on hyperlipidemia
Gleysteen, J. J. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.2.591s · Cited by 92
Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet
Murakami, S., Kondo-Ohta, Y., & Tomisawa, K. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00536-0 · Cited by 89
The low cholesterol-mortality association in a national cohort
Harris, T. B. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90131-6 · Cited by 88
Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy**The sponsor provided the principal investigator with the results of study AI 424-008 before the study's subsequent publication but did not participate in the data analysis presented in this report. A draft of the manuscript was submitted to the sponsor before submission with the understanding that the final manuscript remained under the complete control of the principal investigator.
Grover, S. A., Coupal, L., Gilmore, N. J., & Mukherjee, J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.11.004 · Cited by 87
Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., & Cassader, M. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101107.134820 · Cited by 87
Statins and Renal Function
Elisaf, M., & Mikhailidis, D. P. (2002) · Angiology · doi:10.1177/000331970205300501 · Cited by 85
Pharmacoeconomics of Lipid-Lowering Agents for Primary and Secondary Prevention of Coronary Artery Disease
Hay, J. W., Yu, W., & Ashraf, T. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915010-00004 · Cited by 86
The Helsinki Heart Study: Central Findings and Clinical Implications
Huttunen, J. K., Manninen, V., Mänttäri, M., Koskinen, P., Romo, M., Tenkanen, L., Heinonen, O. P., & Frick, M. H. (1991) · Annals of Medicine · doi:10.3109/07853899109148041 · Cited by 85
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week multicenter, randomized, double-blind, controlled trial
Huijgen, R., Abbink, E. J., Bruckert, E., Stalenhoef, A. F. H., Imholz, B. P. M., Durrington, P. N., Trip, M. D., Eriksson, M., Visseren, F. L. J., Schaefer, J. R., et al. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.04.014 · Cited by 80
Low or lowered cholesterol and risk of death from suicide and trauma
Muldoon, M. F., Rossouw, J. E., Manuck, S. B., Glueck, C. J., Kaplan, J. R., & Kaufmann, P. G. (1993) · Metabolism · doi:10.1016/0026-0495(93)90259-q · Cited by 85
Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?
Modica, S., & Moschetta, A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.082 · Cited by 83
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence
Preiss, D., & Sattar, N. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03490.x · Cited by 80
Statins and stroke: evidence for cholesterol-independent effects
Napoli, P. D. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3236 · Cited by 83
Rho/Rho-Associated Coiled-Coil Forming Kinase Pathway as Therapeutic Targets for Statins in Atherosclerosis
Sawada, N., & Liao, J. K. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5524 · Cited by 81
Low‐density Lipoprotein Apheresis: An Overview
Bambauer, R., Schiel, R., & Latza, R. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00070.x · Cited by 81
Early Time to Benefit with Intensive Statin Treatment: Could It Be the Pleiotropic Effects?
Ray, K. K., & Cannon, C. P. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.027 · Cited by 80
Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease
Koutroumpakis, E., Ramos–Rivers, C., Regueiro, M. D., Hashash, J. G., Barrie, A. M., Swoger, J. M., Baidoo, L., Schwartz, M. B., Dunn, M. A., Κoutroubakis, I. E., et al. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3932-1 · Cited by 79
Bile acid transport systems as pharmaceutical targets
Kramer, W., & Wess, G. (1996) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1996.tb02383.x · Cited by 79
Lipid lowering, regression, and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting.
Gotto, A. (1995) · Circulation · doi:10.1161/01.cir.92.3.646 · Cited by 87
A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels
Carswell, K. A., Belgaumkar, A. P., Amiel, S. A., & Patel, A. G. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1829-x · Cited by 78
Absence of Dysfunctional Ileal Sodium?Bile Acid Cotransporter Gene Mutations in Patients with Adult-Onset Idiopathic Bile Acid Malabsorption
Montagnani, M. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750422693 · Cited by 78
Recent advancements in bariatric/metabolic surgery
Lee, W., & Almalki, O. M. (2017) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12030 · Cited by 75
The Effect of Ezetimibe on Peripheral Arterial Atherosclerosis Depends Upon Statin Use at Baseline
West, A. M., Anderson, J. D., Meyer, C., Epstein, F., Wang, H., Hagspiel, K., Berr, S., Harthun, N., Dimaria, J. M., Hunter, J. R., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.005 · Cited by 87
Dyslipidemia in Non-Insulin-Dependent Diabetes Mellitus
Howard, B. V., & Howard, W. J. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-263 · Cited by 76
Progression and Regression of Coronary Stenosis in the Long-term Follow-up of Vasospastic Angina
Ozaki, Y., Keane, D., & Serruys, P. W. J. C. (1995) · Circulation · doi:10.1161/01.cir.92.9.2446 · Cited by 74

Authors: Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hansen, B. J., Tuna, N., Karnegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., & Chalmers, T. C.
Affiliations: University of Minnesota (US)
University of Southern California (US)
ORCID: Long, John M.
Hunter, David W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1990-10-04
Volume: 323
Issue: 14
Pages: 946-955
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199010043231404
OpenAlex: W2331959986
Cited by: 1,001
References: 58
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 20 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 22 · 2015: 15 · 2014: 17 · 2013: 12 · 2012: 17
FWCI: 84.71
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: partial ileal bypass, hypercholesterolemia, coronary artery disease, mortality, myocardial infarction, cholesterol lowering, LDL cholesterol, HDL cholesterol, first myocardial infarction, coronary artery bypass grafting, ejection fraction, long-term outcomes, nonfatal myocardial infarction
MeSH terms: Adult, Coronary Disease, Electrocardiography, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hyperlipidemias, Jejunoileal Bypass, Lipids, Male, Middle Aged, Ultrasonography, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Coronary Angiography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks